Search results
Your search for XIST returned no results
Showing 76 to 90 of 1556 results for list
Showing 76 to 90 of 1556 results for list
This guideline covers diagnosing and managing gallstone disease in adults. It aims to reduce variation in care by promoting the most effective treatments, and to improve the advice given to people with gallstone disease before and after treatment.
In development Reference number: GID-QS10189 Expected publication date: 07 January 2027
Ex-situ machine perfusion devices for deceased donor liver transplants
In development Reference number: GID-HTE10066 Expected publication date: 20 August 2026
Our indicators measure outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.
Suspected sepsis: recognition, diagnosis and early management - procalcitonin testing
In development Reference number: GID-NG10467 Expected publication date: 15 July 2026
Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip (TA304)
Evidence-based recommendations on artificial hips and hip resurfacing for treating end-stage arthritis of the hip in adults.
View recommendations for TA304Show all sections
Evidence summaries: unlicensed and off-label medicines – Interim process statement (PMG2)
This interim process statement sets out to guide the development of 'Evidence summaries: unlicensed and off-label medicines' (ESUOMs). It provides an overview of the key process principles and describes all stages of development for ESUOMs
This guideline covers good practice for developing, authorising, using and updating patient group directions. It also offers advice on deciding whether a patient group direction is needed.
View recommendations for MPG2Show all sections
Managing common infections - antimicrobial prescribing guidelines
In development Reference number: GID-NG10050 Expected publication date: TBC
In development Reference number: GID-QS10196 Expected publication date: 28 January 2027
In development Reference number: GID-TA11340 Expected publication date: TBC
Awaiting development Reference number: GID-TA10721 Expected publication date: TBC
Evidence-based recommendations on bevacizumab (Avastin), with a taxane, for treating metastatic breast cancer in adults.
Tofacitinib for treating juvenile idiopathic arthritis (TA735)
Evidence-based recommendations on tofacitinib for treating juvenile idiopathic arthritis.
Maralixibat for treating cholestatic pruritus in Alagille syndrome [ID3941]
In development Reference number: GID-TA10832 Expected publication date: TBC